CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Reimbursement scenario

3.3.1.Developed regions
3.3.2.Developing regions

3.4.Government regulations
3.5.Top player positioning, 2019
3.6.Porters five forces analysis
3.7.Market dynamics

3.7.1.Drivers

3.7.1.1.Affordable good quality care
3.7.1.2.Availability of quality care
3.7.1.3.Accessible information and care
3.7.1.4.Assistance and support from government agencies and associations

3.7.2.Restraints

3.7.2.1.Limited coverage and lengthy partial reimbursement by payers
3.7.2.2.Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues

3.7.3.Opportunities

3.7.3.1.Overseas promotional offices are a key source of medical tourists
3.7.3.2.Wider hospital network under insurance coverage for cashless transactions

3.7.4.Impact analyses

3.8.Impact analysis of COVID-19 on the medical tourism market

CHAPTER 4:MEDICAL TOURISM MARKET, BY TREATMENT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Dental Treatment

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.2.2.1.Market size and forecast, by North America
4.2.2.2.Market size and forecast, by Europe
4.2.2.3.Market size and forecast, by Asia-Pacific
4.2.2.4.Market size and forecast, by LAMEA

4.3.Cosmetic Treatment

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.3.2.1.Market size and forecast, by North America
4.3.2.2.Market size and forecast, by Europe
4.3.2.3.Market size and forecast, by Asia-Pacific
4.3.2.4.Market size and forecast, by LAMEA

4.4.Cardiovascular treatment

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region

4.4.2.1.Market size and forecast, by North America
4.4.2.2.Market size and forecast, by Europe
4.4.2.3.Market size and forecast, by Asia-Pacific
4.4.2.4.Market size and forecast, by LAMEA

4.5.Orthopedic treatment

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region

4.5.2.1.Market size and forecast, by North America
4.5.2.2.Market size and forecast, by Europe
4.5.2.3.Market size and forecast, by Asia-Pacific
4.5.2.4.Market size and forecast, by LAMEA

4.6.Neurological treatment

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region

4.6.2.1.Market size and forecast, by North America
4.6.2.2.Market size and forecast, by Europe
4.6.2.3.Market size and forecast, by Asia-Pacific
4.6.2.4.Market size and forecast, by LAMEA

4.7.Cancer treatment

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region

4.7.2.1.Market size and forecast, by North America
4.7.2.2.Market size and forecast, by Europe
4.7.2.3.Market size and forecast, by Asia-Pacific
4.7.2.4.Market size and forecast, by LAMEA

4.8.Fertility treatment

4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region

4.8.2.1.Market size and forecast, by North America
4.8.2.2.Market size and forecast, by Europe
4.8.2.3.Market size and forecast, by Asia-Pacific
4.8.2.4.Market size and forecast, by LAMEA

4.9.Other treatments

4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region

4.9.2.1.Market size and forecast, by North America
4.9.2.2.Market size and forecast, by Europe
4.9.2.3.Market size and forecast, by Asia-Pacific
4.9.2.4.Market size and forecast, by LAMEA

CHAPTER 5:MEDICAL TOURISM MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by treatment type

5.2.3.1.U.S. market size and forecast

5.2.3.1.1.U.S. Medical Tourism MARKET, 2019-2027 ($million)
5.2.3.1.2.Market size and forecast, by treatment type

5.2.3.2.Canada market size and forecast

5.2.3.2.1.Market size and forecast, by treatment type

5.2.3.3.Mexico market size and forecast

5.2.3.3.1.Market size and forecast, by treatment type

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by treatment type

5.3.3.1.Germany market size and forecast

5.3.3.1.1.Market size and forecast, by treatment type

5.3.3.2.France market size and forecast

5.3.3.2.1.Market size and forecast, by treatment type

5.3.3.3.UK market size and forecast

5.3.3.3.1.Market size and forecast, by treatment type

5.3.3.4.Italy market size and forecast

5.3.3.4.1.Market size and forecast, by treatment type

5.3.3.5.Spain market size and forecast

5.3.3.5.1.Market size and forecast, by treatment type

5.3.3.6.Rest of Europe market size and forecast

5.3.3.6.1.Market size and forecast, by treatment type

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by treatment type

5.4.3.1.India market size and forecast

5.4.3.1.1.Market size and forecast, by treatment type

5.4.3.2.China market size and forecast

5.4.3.2.1.Market size and forecast, by treatment type

5.4.3.3.Indonesia market size and forecast

5.4.3.3.1.Market size and forecast, by treatment type

5.4.3.4.Singapore market size and forecast

5.4.3.4.1.Market size and forecast, by treatment type

5.4.3.5.Malaysia market size and forecast

5.4.3.5.1.Market size and forecast, by treatment type

5.4.3.6.Thailand market size and forecast

5.4.3.6.1.Market size and forecast, by treatment type

5.4.3.7.South Korea market size and forecast

5.4.3.7.1.Market size and forecast, by treatment type

5.4.3.8.Taiwan market size and forecast

5.4.3.8.1.Market size and forecast, by treatment type

5.4.3.9.Rest of Asia-Pacific market size and forecast

5.4.3.9.1.Market size and forecast, by treatment type

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by treatment type

5.5.3.1.Brazil market size and forecast

5.5.3.1.1.Market size and forecast, by treatment type

5.5.3.2.Venezuela market size and forecast

5.5.3.2.1.Market size and forecast, by treatment type

5.5.3.3.Costa Rica market size and forecast

5.5.3.3.1.Market size and forecast, by treatment type

5.5.3.4.UAE market size and forecast

5.5.3.4.1.Market size and forecast, by treatment type

5.5.3.5.South Africa market size and forecast

5.5.3.5.1.Market size and forecast, by treatment type

5.5.3.6.Rest of LAMEA market size and forecast

5.5.3.6.1.Market size and forecast, by treatment type

CHAPTER 6:COMPANY PROFILE

6.1.APOLLO HOSPITALS ENTERPRISE LIMITED

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments

6.2.FORTIS HEALTHCARE LIMITED

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance

6.3.ASIAN HEART INSTITUTE

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio

6.4.KPJ HEALTHCARE BERHAD

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance

6.5.NTT Medical Center Tokyo

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments

6.6.SEOUL NATIONAL UNIVERSITY HOSPITAL.

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio

6.7.UZ LEUVEN

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio

6.8.WOORIDUL SPINE HOSPITAL

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Product Portfolio

6.9.ADITYA BIRLA MEMORIAL HOSPITAL

6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio

6.10.BARBADOS FERTILITY CENTER

6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio

6.11.PRINCE COURT MEDICAL CENTRE

6.11.1.Company overview
6.11.2.Company snapshot
6.11.3.Operating business segments
6.11.4.Product portfolio

6.12.SAMITIVEJ PCL.

6.12.1.Company overview
6.12.2.Company snapshot
6.12.3.Operating business segments
6.12.4.Product portfolio